Salud financiera de hoja de balance de Vivotek

Salud financiera controles de criterios 6/6

Vivotek tiene un patrimonio de accionistas total de NT$3.6B y una deuda total de NT$455.3M, lo que sitúa su ratio deuda-patrimonio en 12.6%. Sus activos y pasivos totales son NT$6.4B y NT$2.8B respectivamente. El BAIT de Vivotek es de NT$422.7M, por lo que su ratio de cobertura de intereses es de -559.9. Tiene efectivo e inversiones a corto plazo que ascienden a NT$2.2B.

Información clave

11.7%

Ratio deuda-patrimonio

NT$425.58m

Deuda

Ratio de cobertura de intereses	-327.7x
Efectivo	NT$2.07b
Patrimonio	NT$3.63b
Total pasivo	NT$2.47b
Activos totales	NT$6.11b

Actualizaciones recientes sobre salud financiera

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

Mar 12

We Think Vivotek (TPE:3454) Can Stay On Top Of Its Debt

Dec 08

Recent updates

Vivotek Inc. (TPE:3454) Investors Should Think About This Before Buying It For Its Dividend

Apr 16

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

Mar 12

The Trends At Vivotek (TPE:3454) That You Should Know About

Feb 21

Can Vivotek Inc.'s (TPE:3454) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Jan 31

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$5.0B) de 3454 superan a sus pasivos a corto plazo (NT$2.6B).

Pasivo a largo plazo: Los activos a corto plazo de 3454 (NT$5.0B) superan a sus pasivos a largo plazo (NT$207.4M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 3454 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 3454 ha pasado de 17.3% a 12.6% en los últimos 5 años.

Cobertura de la deuda: La deuda de 3454 está bien cubierta por el flujo de caja operativo (360.1%).

Cobertura de intereses: 3454 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.

Salud financiera de hoja de balance de Vivotek

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

We Think Vivotek (TPE:3454) Can Stay On Top Of Its Debt

Recent updates

Vivotek Introduces Ai Entry-Tier 9383-Series Network Camera for All-Around Ai Solution

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Vivotek Inc. Announces Board and Committee Changes

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Vivotek Inc., Annual General Meeting, May 31, 2024

Vivotek Introducing Global Five-Year Warranty, Elevating After-Sales Service to Uphold Sustainable Commitment

Vivotek Inc. Announces Establishment of Risk Management Committee

Vivotek Inc. Announces of Change of Representative by A Juristic Person Director of the Company

New major risk - Revenue and earnings growth

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Share price stability

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of NT$5.50 per share at 2.8% yield

Vivotek Inc. Announces Cash Dividend Distribution, Payable on August 31, 2023

Vivotek Inc. Announces Election of New member in Compensation Committee

Vivotek Inc. Approves Cash Dividend for 2022

Investor sentiment improves as stock rises 20%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$2.56 (vs NT$0.25 loss in 3Q 2021)

Investor sentiment improved over the past week

VIVOTEK Showcases Next-Generation VMS, VAST Security Station

Investor sentiment improved over the past week

VIVOTEK Launches Highly Anticipated VORTEX AI Surveillance Cloud Service Solution

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: NT$1.57 (vs NT$1.00 in 2Q 2021)

Upcoming dividend of NT$1.40 per share

Vivotek Inc. Approves 2021 Earnings Distribution

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Vivotek Inc., Annual General Meeting, Jun 17, 2022

Third quarter 2021 earnings released: NT$0.25 loss per share (vs NT$0.76 profit in 3Q 2020)

Upcoming dividend of NT$2.00 per share

Second quarter 2021 earnings released: EPS NT$1.00 (vs NT$0.53 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.60 (vs NT$1.02 in 1Q 2020)

Vivotek Inc. (TPE:3454) Investors Should Think About This Before Buying It For Its Dividend

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

Kneron, Inc. signed a share exchange agreement to acquire VATICS INC from Vivotek Inc. (TSEC:3454) for TWD 46.63 million.

Vivotek Inc., Annual General Meeting, Jun 16, 2021

Full year 2020 earnings released: EPS NT$2.90 (vs NT$3.19 in FY 2019)

The Trends At Vivotek (TPE:3454) That You Should Know About

Can Vivotek Inc.'s (TPE:3454) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Is Vivotek Inc. (TPE:3454) A Strong Dividend Stock?

Did You Participate In Any Of Vivotek's (TPE:3454) Respectable 60% Return?

New 90-day high: NT$82.30

We Think Vivotek (TPE:3454) Can Stay On Top Of Its Debt

Has Vivotek (TPE:3454) Got What It Takes To Become A Multi-Bagger?

Third quarter 2020 earnings released: EPS NT$0.76

Third quarter earnings released

CyberLink Corp. Collaborates with VIVOTEK to Integrate CyberLink’s FaceMe® Security

New 90-day high - NT$81.40

First half earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera